Knee Bursitis Market Research Report - Forecast till 2027

Knee Bursitis Market Research Report Information: By Diagnosis (Imaging Test (X-Ray, Ultrasound)), Treatment (Medication, Surgery (Corticosteroid Injection)) End User (Hospitals & Clinics, Diagnostic Centers, Research Centers) – Forecast till 2027

ID: MRFR/Pharma/3965-HCR | | Region : Global

Knee Bursitis Market Scenario:


Knee bursitis is inflammation of a small fluid-filled sac (bursa) situated near the knee joint. Bursae reduce friction and cushion pressure points between bones and the tendons, muscles, and skin near joints. Knee bursitis signs and symptoms vary, depending on which bursa is affected and what's causing the inflammation. Generally, the affected portion of knee might feel warm, tender, and swollen when pressure is applied. But most cases of knee bursitis result from friction and irritation of the bursa that occurs in jobs that require a lot of kneeling on hard surfaces. Knee bursitis can be caused by frequent and sustained pressure, such as kneeling, especially on hard surfaces, overuse or strenuous activity, a direct blow to the knee, a bacterial infection of the bursa, complications from osteoarthritis, and others. Risk factors for knee bursitis is a common complaint, but the risk of developing this painful disorder can increase from prolonged kneeling. For instance, people who work on their knees for long periods such as carpet layers, plumbers, and gardeners are at increased risk of knee bursitis. Sports that result in direct blows or frequent falls on the knee such as wrestling, football, and volleyball can increase your risk of knee bursitis. Runners can develop pain and inflammation in the pes anserine bursa, situated on the inner side knee below the joint.

The global knee bursitis market is expecting a sound growth in the coming future owing to the increasing prevalence of bone-related diseases and favorable reimbursement policies. Mostly all diabetic patients suffer from some or the other knee bursitis. According to findings from the WHO in 2014, approximately 422 million people reported suffering from diabetes. Due to the increasing diabetic population across the globe, there is a significant increase in the number of people with knee bursitis. Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of the market. On the other hand, strict regulatory rules and the high cost of the treatment methods may slow the growth of the market during the forecast period.

The knee bursitis market size is expected to grow at a CAGR of 7.1% during the forecast period 2017-2023.

Figure- Global Knee Bursitis Market, by region 2016(%) Knee Bursitis Market

Knee Bursitis Market Segments        

The global knee bursitis market has been segmented on the basis of diagnosis, treatment, and end users.

On the basis of the diagnosis, the global knee bursitis market is segmented into imaging tests and others. Imaging tests are further segmented into X-ray, MRI, ultrasound, and others.

Based on the treatment, it is segmented medication, therapy, surgery, and others. Medication is sub-segmented into antibiotic treatment and others. Others segment includes corticosteroid injection and others.

On the basis of the end users, the market is segmented into hospitals & clinics, diagnostic centers, research centers, academic institutes, and others.

Knee Bursitis Market Regional analysis                    

The Americas accounted for the major share of the market owing to the presence of a huge population of patients suffering from bone related problems or joint pains, high healthcare expenditure, well-developed technology, and the presence of the leading players. Furthermore, rising government support for the development of the advanced devices and well-developed healthcare sector has boosted the growth of the knee bursitis market in the Americas.

Europe accounted for the second largest market for the knee bursitis, which is followed by Asia Pacific. Increasing prevalence of the knee bursitis, diabetes, and huge healthcare spending are the major driving factors that have boosted the market growth. Additionally, the healthcare expenditure in this region is also rising. People and healthcare organizations in this region are able to afford the high cost of the devices, which is driving the growth of the market. Furthermore, increasing government support and funding for the development and improvement of the treatments have fuelled the growth of the market. 

The Asia Pacific is the fastest growing knee bursitis market. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool is driving the growth of the market in this region.

The Middle East & Africa holds the least share of the market owing to the presence of poor and slow developing countries, especially, in the African region. The major driving factors for the growth of the Middle East & African knee bursitis market are increasing aging population and increasing number of diabetic patients.


Key players in the Knee Bursitis Market:                                                    



  • Novartis AG

  • Pfizer Inc

  • Amgen Inc

  • AVEO Pharmaceuticals Inc

  • Bayer AG

  • Bellicum Pharmaceuticals Inc

  • MediaPharma srl

  • Merck & Co., Inc

  • Merrimack Pharmaceuticals Inc

  • Oncolys BioPharma Inc

  • United Therapeutics Corp 




Intended Audience



  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Research Methodology Knee Bursitis Market 2018 Source: U.S. National Library of Medicine, U.S. Food and Drug Administration, U.S. Department of Health and Human Services, National Institutes of Health, Expert Interview, Annual report, White paper, Company Presentation, MRFR Analysis

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Knee Bursitis Market, by Diagnosis

6.1 Introduction

6.2 Imaging Tests

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Others

6.3.1 Market Estimates & Forecast, 2020-2027

7. Global Knee Bursitis Market, by Treatment

7.1 Introduction

7.2 Medication

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Surgery

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Others

7.4.1 Market Estimates & Forecast, 2020-2027

8. Global Knee Bursitis Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Diagnostic Centers

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Others

8.4.1 Market Estimates & Forecast, 2020-2027

9. Global Knee Bursitis Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11. Company Profiles

11.1 Novartis AG

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Pfizer Inc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Amgen Inc

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 AVEO Pharmaceuticals Inc

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Bayer AG

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Bellicum Pharmaceuticals Inc

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 MediaPharma srl

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix

LIST OF TABLES

Table 1 Knee Bursitis Industry Synopsis, 2020-2027

Table 2 Global Knee Bursitis Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Knee Bursitis Market by Region, 2020-2027, (USD Million)

Table 4 Global Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 5 Global Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 6 Global Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 7 North America Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 8 North America Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 10 North America Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 11 U.S. Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 12 U.S. Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 13 U.S. Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 14 Canada Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 15 Canada Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 16 Canada Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 17 South America Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 18 South America Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 19 South America Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 20 Europe Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 21 Europe Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 22 Europe Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 23 Western Europe Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 24 Western Europe Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 25 Western Europe Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 26 Eastern Europe Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 27 Eastern Europe Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 28 Eastern Europe Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 29 Asia Pacific Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 30 Asia Pacific Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 31 Asia Pacific Knee Bursitis Market by End Users, 2020-2027, (USD Million)

Table 32 Middle East & Africa Knee Bursitis Market by Diagnosis, 2020-2027, (USD Million)

Table 32 Middle East & Africa Knee Bursitis Market by Treatment, 2020-2027, (USD Million)

Table 33 Middle East & Africa Knee Bursitis Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Knee Bursitis Market

Figure 3 Segmentation Market Dynamics for Knee Bursitis Market

Figure 4 Global Knee Bursitis Market Share, by Treatment 2020

Figure 5 Global Knee Bursitis Market Share, by End Users, 2020

Figure 6 Global Knee Bursitis Market Share, by Region, 2020

Figure 7 North America Knee Bursitis Market Share, by Country, 2020

Figure 8 Europe Knee Bursitis Market Share, by Country, 2020

Figure 9 Asia Pacific Knee Bursitis Market Share, by Country, 2020

Figure 10 Middle East & Africa Knee Bursitis Market Share, by Country, 2020

Figure 11 Global Knee Bursitis Market: Company Share Analysis, 2020 (%)

Figure 12 Novartis AG: Key Financials

Figure 13 Novartis AG: Segmental Revenue

Figure 14 Novartis AG: Geographical Revenue

Figure 15 Pfizer Inc: Key Financials

Figure 16 Pfizer Inc: Segmental Revenue

Figure 17 Pfizer Inc: Geographical Revenue

Figure 18 Amgen Inc: Key Financials

Figure 19 Amgen Inc: Segmental Revenue

Figure 20 Amgen Inc: Geographical Revenue

Figure 21 AVEO Pharmaceuticals Inc: Key Financials

Figure 22 AVEO Pharmaceuticals Inc: Segmental Revenue

Figure 23 AVEO Pharmaceuticals Inc: Geographical Revenue

Figure 24 Bayer AG: Key Financials

Figure 25 Bayer AG: Segmental Revenue

Figure 26 Bayer AG: Geographical Revenue

Figure 27 Bellicum Pharmaceuticals Inc: Key Financials

Figure 28 Bellicum Pharmaceuticals Inc: Segmental Revenue

Figure 29 Bellicum Pharmaceuticals Inc: Geographical Revenue

Figure 30 MediaPharma srl: Key Financials

Figure 31 MediaPharma srl: Segmental Revenue

Figure 32 MediaPharma srl: Geographical Revenue

Knee Bursitis Market